Search - tctmd.com

Displaying 261 - 280 of 423

Sort: Relevancy | Date

Presentation TCT 2015

Restenosis Patterns After DCB and Management Strategies

Presenter: Krishna J. Rocha-Singh, Andrej Schmidt, Gunnar Tepe

October 12, 2015

Presentation TCT 2015

DCB Treatment of In-Stent Restenosis With or Without Upfront Debulking: Updated Results

Presenter: John R. Laird Jr, Gunnar Tepe, Thomas Zeller

October 12, 2015

Presentation TCT 2015

Case Presentation Before Second-Time Treatment: Recurrent DES Restenosis

Presenter: Robert A. Byrne, Stefan K. James, Wojtek Wojakowski

October 11, 2015

$The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond$

Presentation TCT 2015

The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond

Presenter: Robert A. Byrne, Stefan K. James, Paul S. Teirstein

October 11, 2015

Presentation TCT 2015

Drug-Eluting Stent Restenosis State of the Art: Causes, Evaluation, and Treatment

Presenter: Robert A. Byrne, Stefan K. James, Fernando Alfonso

October 11, 2015

Presentation TCT 2015

How Was the Case Treated

Presenter: Robert A. Byrne, Stefan K. James, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Case Presentation Before Treatment: An Unexpected and Difficult to Treat Stent Thrombosis

Presenter: Robert A. Byrne, Stefan K. James, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

Presenter: Robert A. Byrne, Stefan K. James, Donald Cutlip

October 11, 2015

Presentation TCT 2015

New Insights Into Neoatherosclerosis as a Frequent Common Denominator of DES Failure

Presenter: Robert A. Byrne, Stefan K. James, Renu Virmani

October 11, 2015

Presentation TCT 2015

Stent Thrombosis Update: Causes, Predictors, Implications, and Treatment

Presenter: Robert A. Byrne, Stefan K. James

October 11, 2015

Presentation TCT 2015

Update on Neoatherosclerosis: Imaging Recognition, Prevalence, Predictors, and Prognosis

Presenter: Soo-Jin Kang, Gary S. Mintz, Ziad A. Ali

October 11, 2015

Presentation TCT 2015

Does Acute or Late Malapposition Cause Stent Thrombosis?

Presenter: Soo-Jin Kang, Gary S. Mintz

October 11, 2015

Presentation TCT 2015

Mechanisms and Predictors of Early, Late, and Very Late Stent Thrombosis

Presenter: Soo-Jin Kang, Gary S. Mintz, Lisette Okkels Jensen

October 11, 2015

Presentation TCT 2015

Mechanisms and Predictors and Treatment of In-Stent Restenosis

Presenter: Soo-Jin Kang, Gary S. Mintz

October 11, 2015

Presentation TCT 2015

Management Strategies for SFA/Popliteal In-Stent Restenosis

Presenter: Hans Krankenberg, Lindsay S. Machan

October 11, 2015

Presentation TCT 2015

Restenosis and Stent Thrombosis

Presenter: George D. Dangas, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Adventitial Injection Therapy for Restenosis: Rationale and Clinical Results to Date

Presenter: Prakash Krishnan, Mahmood K. Razavi, Christopher D. Owens

October 11, 2015

Presentation

Predictors of Restenosis After Contemporary Subintimal Tracking and Reentry Technique (STAR)

Presenter: Mauro Carlino

September 14, 2015

Presentation

RIBS IV: Drug-Coated Balloon (DCB) vs Everolimus-Eluting Stent (EES) in Patients With In-Stent Restenosis of DES

Presenter: Fernando Alfonso

June 30, 2015

Presentation

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty in Patients With DES Restenosis

Presenter: Seiji Habara

June 30, 2015

Advertisement

Restenosis Patterns After DCB and Management Strategies

DCB Treatment of In-Stent Restenosis With or Without Upfront Debulking: Updated Results

Case Presentation Before Second-Time Treatment: Recurrent DES Restenosis

The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond

Drug-Eluting Stent Restenosis State of the Art: Causes, Evaluation, and Treatment

How Was the Case Treated

Case Presentation Before Treatment: An Unexpected and Difficult to Treat Stent Thrombosis

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

New Insights Into Neoatherosclerosis as a Frequent Common Denominator of DES Failure

Stent Thrombosis Update: Causes, Predictors, Implications, and Treatment

Update on Neoatherosclerosis: Imaging Recognition, Prevalence, Predictors, and Prognosis

Does Acute or Late Malapposition Cause Stent Thrombosis?

Mechanisms and Predictors of Early, Late, and Very Late Stent Thrombosis

Mechanisms and Predictors and Treatment of In-Stent Restenosis

Management Strategies for SFA/Popliteal In-Stent Restenosis

Restenosis and Stent Thrombosis

Adventitial Injection Therapy for Restenosis: Rationale and Clinical Results to Date

Predictors of Restenosis After Contemporary Subintimal Tracking and Reentry Technique (STAR)

RIBS IV: Drug-Coated Balloon (DCB) vs Everolimus-Eluting Stent (EES) in Patients With In-Stent Restenosis of DES

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty in Patients With DES Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content